deferoxamine has been researched along with hydroxocobalamin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wirth, W | 1 |
| Bowden, CA; Krenzelok, EP | 1 |
| Akatov, VS; Soloviev, VV; Solovieva, ME | 1 |
1 review(s) available for deferoxamine and hydroxocobalamin
| Article | Year |
|---|---|
Clinical applications of commonly used contemporary antidotes. A US perspective.
Topics: Acetylcysteine; Antidotes; Antivenins; Atropine; Deferoxamine; Flumazenil; Humans; Hydroxocobalamin; Naloxone; Physostigmine; Poisoning; Succimer | 1997 |
2 other study(ies) available for deferoxamine and hydroxocobalamin
| Article | Year |
|---|---|
[Possible side-effects of antidotal therapy].
Topics: Antidotes; Atropine; Chelating Agents; Cyanides; Deferoxamine; Dimercaprol; Edetic Acid; Humans; Hydroxocobalamin; Metals; Nitrites; Penicillamine; Pentetic Acid; Phenols; Phosphates; Poisoning; Pralidoxime Compounds; Thiosulfates | 1968 |
Vitamin B12b increases the cytotoxicity of short-time exposure to ascorbic acid, inducing oxidative burst and iron-dependent DNA damage.
Topics: Antioxidants; Apoptosis; Ascorbic Acid; Cell Line, Tumor; Cell Survival; Deferoxamine; DNA Breaks, Single-Stranded; Humans; Hydrogen Peroxide; Hydroxocobalamin; Iron; Iron Chelating Agents; Oxidative Stress; Phenanthrolines; Respiratory Burst; Vitamins | 2007 |